Tangeretin /603

Total Page:16

File Type:pdf, Size:1020Kb

Tangeretin /603 SUPPLEMENT MONOGRAPHS TANGERETIN /603 carbon dioxide and methane; and lactate, pyruvate, succinate LITERATURE and formate. Acetate, propionate and butyrate that are not Collins MO, Gibson GR. Probiotics, prebiotics, and synbiotics: metabolized in colonocytes are absorbed from the colon and approaches for modulating the microbial ecology of the gut. Am transported via the portal circulation to the liver. These J Clin Nutr. 1999; 69(suppl): 10525-10575. short-chain fatty acids are extensively metabolized in hepato- Macfarlane GT, Cummings JH. Probiotics and prebiotics: can cytes. Acetate, propionate and butyrate that are not metabo- regulating the activities of intestinal bacteria benefit health? lized in hepatocytes are transported by the circulation to West J Med. 1999; 17:187-191. various tissues where they undergo further metabolism. Roberfroid MB. Prebiotics and synbiotics: concepts and Butyrate is an important respiratory fuel for colonocytes. nutritional properties. Br J Nutr. 1998; 80:5197-5202. INDICATIONS AND USAGE For additional Literature, see Prebiotics and Probiotics. Synbiotics are useful for the same indications as prebiotics and probiotics. Some may protect against intestinal patho- gens and ameliorate the severity of some inflammatory bowel diseases. Some may be helpful in antibiotic associated Tangeretin diarrhea, as well as some infectious and viral diarrheas. They may have some immune-enhancing, anticarcinogenic, anti- DESCRIPTION osteoporotic, glucose-modulating and lipid-modulating Tangeretin is a member of the polymethoxylated flavone, or effects. polymethoxyflavone, family of flavones. Flavones them- selves comprise a subclass of the large class of plant RESEARCH SUMMARY substances, the flavonoids. Polymethoxylated flavones See Probiotics and Prebiotics. (PMFs) exist almost exclusively in the Citrus genus, particularly in the peels and tissues of sweet oranges (Citrus CONTRAINDICATIONS, PRECAUTIONS, ADVERSE REACTIONS sinensis), the peels and tissues of bitter oranges (Citrus CONTRAINDICA TIONS Synbiotics are contraindicated in those who are hypersensi- aurantium L.) and, especially, in the peels and tissues of tive to any component of a synbiotic-containing supplement. tangerines (Citrus reticulata Blanco), including Dancy and Cleopatra tangerines and clementines. The two most com- PRECAUTIONS mon PMFs found in citrus peels and tissues are nobiletin (see Pregnant women and nursing mothers should only use Nobiletin) and tangeretin. Sinensetin is the third most synbiotic supplementation if prescribed by their physicians. common PMF found in the peels and tissues of citrus fruits. Only trace amounts of tangeretin, at best, are found in ADVERSE REACTIONS lemons (Citrus limon) and grapefruits (Citrus paradisi). The most common adverse reaction to synbiotics is flatulence. Tangeretin, like other flavonoids, is a plant secondary metabolite. Plant secondary metabolites comprise the de- INTERACTIONS fense system of plants against fungi, predators and pests, NUTRITIONAL SUPPLEMENTS among other things. Tangeretin possesses activity against Minerals (calcium, magnesium): Concomitant intake of certain fungal diseases, such as mal seco, an often fatal calcium or magnesium supplements and synbiotics may disease of horses in Argentina. However, tangere tin is not enhance the colonic absorption of these minerals. nearly as potent in this regard as is nobiletin (see Nobiletin). FOODS Tangeretin has been studied for its possible lipid-lowering Synbiotics, via their prebiotic oligosaccharides, may enhance activity, as well as for its possible anticancer activity. the colonic absorption of calcium and magnesium in foods. Tangeretin is chemically described as 5,6,7,8-tetramethoxy- DOSAGE AND ADMINISTRATION Synbiotic supplements that are currently available include 2-(4-methoxyphenyl)-4H-I-benzopyran-4-one. It is also combinations of bifidobacteria and fructo-oligosaccharides known as 4',5,6,7,8-pentamethoxyflavone, and ponkanetin (FOS), Lactobacillus GG and inulins and bifidobacteria and (ponkan is the conventional name for Citrus reticulata). Its lactobacilli and FOS or inulins. New combinations are CAS number is 48 I-53-8. Its empirical formula is C2oH2007 currently being developed. and its molecular weight is 372.37. The major chemical difference between tangeretin and nobiletin is the absence of Probiotic intake typically ranges from one to ten billion a 3'-methoxy group on the flavone skeleton in tangeretin and colony-forming units a few times a week. Doses of the presence of a 3'- methoxy group on the flavone skeleton prebiotics, in the form of synbiotics, are variable. in nobiletin. 604/TANGERETIN PDR FOR NUTRITIONAL SUPPLEMENTS The following chemical structures are described within this Antifungal: The antifungal mechanism of action of tangeretin monograph. is not entirely clear. Hypolipidemic: Apolipoprotein B (apoB) is the primary MeO apolipoprotein of low-density lipoprotein (LDL), which is responsible for carrying cholesterol to tissues. The role of tangeretin on the regulation of apoB and lipid metabolism MeO was studied in the human hepatoma cell line HepG2. It was OMeO found that tangeretin significantly lowered apoB secretion and decreased intracellular synthesis of cholesteryl esters, Tangeretin free cholesterol and triacylglycerol (TAG). The suppression of TAG synthesis went along with lowered activity of diacylglycerol (DAG) acyltransferase (DGAT) and micro- somal triglyceride transfer protein (MTP). Tangeretin was also found to activate the peroxisome proliferator-activated receptor (PPAR). PPAR is a transcription factor that has a o positive regulatory impact on fatty acid oxidation and TAG availability. Flavone Skeleton Citrus polymethoxylated flavones (PMFs), especially tanger- 4' etin, were found to significantly lower total cholesterol, very 7 3' low-density lipoprotein (VLDL) and LDL-cholesterol in hamsters with diet-induced hypercholesterolemia. The PMFs 6 reduced or tended to reduce serum triglyceride levels, as well. High-density lipoprotein cholesterol (HDL) was not affected. The mechanism of this lipid-lowering effect is Flavonoid Skeleton unclear. ACTIONS AND PHARMACOLOGY The hypolipidemic effect of tangeretin in human HepG2 ACTIONS cells along with its hypocholesterolemic effect in hamsters Tangeretin has antifungal activity against some citrus warrants further study as well as human trials to determine if pathogenic fungi. Tangeretin has possible anticancer and tangeretin might have a role in the management of hypolipidemic activities. hyperlipidemia. MECHANISM OF ACTION PHARMACOKINETICS Anticancer activity: Tangeretin was found to induce cell- The pharmacokinetics (PK) of tangeretin IS incomplete. cycle G I arrest in human colorectal carcinoma COLa 205 Almost all of the PK studies of tangeretin have been cells, inhibiting the growth of these cells. The polymethoxy- performed in animals. Tangeretin is absorbed across the lated flavone was demonstrated to inhibit the activities of small intestine to some degree. Tangeretin has very low cyclin-dependent kinases 2 (Cdk2) and 4 (Cdk4). In addition, solubility in water, but its permeability is quite high, which the Cdk inhibitors p21 and p27 were also shown to be ultimately contributes to fair bioavailability for this citrus elevated with the tangeretin treatment. Tangeretin possibly flavone. Tangeretin, following absorption, most likely enters exerted its growth inhibitory effect either via modulation of first into the lymphatics and is transported to the systemic the activities of several key G I regulatory proteins (Cdk2, circulation, which transports it to various tissues and organs, Cdk4) or via mediating the increase of Cdk inhibitors (p21, including the liver. It has been reported that tangeretin p27). More research is needed to understand this growth crosses the blood-brain barrier and, in a rat study, it was inhibitory effect of tangeretin. found in the hypothalamus, the striatum and the hippocam- pus. In contrast to polyphenolic flavonoids, tangeretin itself Tangeretin was demonstrated to inhibit the growth of human is not glucuronidated by UDP-glucuronosyltransferase to a mammary cells. In estradiol-primed human T47D mammary glucuronide. Nor does it get sulfated by sulfotransferases to a cancer cells, it was observed that tangeretin inhibited sulfate. This is because the hydroxyl groups are methylated. extracellular signal-regulated kinases 1/2 (ERK 1/2) phospho- rylation. It was thought that this kinase inhibitory action However, when the methoxy groups get demethylated, accounted, in part, for the inhibition of mammary cell phenolic hydroxyl groups open up, which can be glucuroni- growth. dated or sulfated. Metabolites of tangeretin that have been SUPPLEMENT MONOGRAPHS TANGERETIN /605 found in rat urine include monohydroxytetramethoxy fla- One group has reported that formulations containing citrus vone, dihydroxytrimethoxy flavone and glucuronide conju- PMFs, primarily tangeretin, show some promise as cholester- gates of the flavones. ol- and triacylglycerol-Iowering agents. These conclusions were based upon both in vitro and animal studies. One of the INDICATIONS AND USAGE same researchers, in collaboration with others, has also Clinical evidence in support of the claim that the citrus reported that PMFs ameliorate fructose-induced hyperglycer- flavonoid tangeretin is therapeutic in breast and some other idemia and other metabolic abnormalities associated with cancers is lacking. There is very preliminary nonclinical data insulin
Recommended publications
  • Identification of Compounds That Rescue Otic and Myelination
    RESEARCH ARTICLE Identification of compounds that rescue otic and myelination defects in the zebrafish adgrg6 (gpr126) mutant Elvira Diamantopoulou1†, Sarah Baxendale1†, Antonio de la Vega de Leo´ n2, Anzar Asad1, Celia J Holdsworth1, Leila Abbas1, Valerie J Gillet2, Giselle R Wiggin3, Tanya T Whitfield1* 1Bateson Centre and Department of Biomedical Science, University of Sheffield, Sheffield, United Kingdom; 2Information School, University of Sheffield, Sheffield, United Kingdom; 3Sosei Heptares, Cambridge, United Kingdom Abstract Adgrg6 (Gpr126) is an adhesion class G protein-coupled receptor with a conserved role in myelination of the peripheral nervous system. In the zebrafish, mutation of adgrg6 also results in defects in the inner ear: otic tissue fails to down-regulate versican gene expression and morphogenesis is disrupted. We have designed a whole-animal screen that tests for rescue of both up- and down-regulated gene expression in mutant embryos, together with analysis of weak and strong alleles. From a screen of 3120 structurally diverse compounds, we have identified 68 that reduce versican b expression in the adgrg6 mutant ear, 41 of which also restore myelin basic protein gene expression in Schwann cells of mutant embryos. Nineteen compounds unable to rescue a strong adgrg6 allele provide candidates for molecules that may interact directly with the Adgrg6 receptor. Our pipeline provides a powerful approach for identifying compounds that modulate GPCR activity, with potential impact for future drug design. DOI: https://doi.org/10.7554/eLife.44889.001 *For correspondence: [email protected] †These authors contributed Introduction equally to this work Adgrg6 (Gpr126) is an adhesion (B2) class G protein-coupled receptor (aGPCR) with conserved roles in myelination of the vertebrate peripheral nervous system (PNS) (reviewed in Langenhan et al., Competing interest: See 2016; Patra et al., 2014).
    [Show full text]
  • GRAS Notice (GRN) No. 719, Orange Pomace
    GRAS Notice (GRN) No. 719 https://www.fda.gov/Food/IngredientsPackagingLabeling/GRAS/NoticeInventory/default.htm SAFETY EVALUATION DOSSIER SUPPORTING A GENERALLY RECOGNIZED AS SAFE (GRAS) CONCLUSION FOR ORANGE POMACE SUBMITTED BY: PepsiCo, Inc. 700 Anderson Hill Road Purchase, NY 10577 SUBMITTED TO: U.S. Food and Drug Administration Center for Food Safety and Applied Nutrition Office of Food Additive Safety HFS-200 5100 Paint Branch Parkway College Park, MD 20740-3835 CONTACT FOR TECHNICAL OR OTHER INFORMATION: Andrey Nikiforov, Ph.D. Toxicology Regulatory Services, Inc. 154 Hansen Road, Suite 201 Charlottesville, VA 22911 July 3, 2017 Table of Contents Part 1. SIGNED STATEMENTS AND CERTIFICATION ...........................................................1 A. Name and Address of Notifier .............................................................................................1 B. Name of GRAS Substance ...................................................................................................1 C. Intended Use and Consumer Exposure ................................................................................1 D. Basis for GRAS Conclusion ................................................................................................2 E. Availability of Information ..................................................................................................3 Part 2. IDENTITY, METHOD OF MANUFACTURE, SPECIFICATIONS, AND PHYSICAL OR TECHNICAL EFFECT.................................................................................................4
    [Show full text]
  • (Piper Nigrum L.) Products Based on LC-MS/MS Analysis
    molecules Article Nontargeted Metabolomics for Phenolic and Polyhydroxy Compounds Profile of Pepper (Piper nigrum L.) Products Based on LC-MS/MS Analysis Fenglin Gu 1,2,3,*, Guiping Wu 1,2,3, Yiming Fang 1,2,3 and Hongying Zhu 1,2,3,* 1 Spice and Beverage Research Institute, Chinese Academy of Tropical Agricultural Sciences, Wanning 571533, China; [email protected] (G.W.); [email protected] (Y.F.) 2 National Center of Important Tropical Crops Engineering and Technology Research, Wanning 571533, China 3 Key Laboratory of Genetic Resources Utilization of Spice and Beverage Crops, Ministry of Agriculture, Wanning 571533, China * Correspondence: [email protected] (F.G.); [email protected] (H.Z.); Tel.: +86-898-6255-3687 (F.G.); +86-898-6255-6090 (H.Z.); Fax: +86-898-6256-1083 (F.G. & H.Z.) Received: 16 July 2018; Accepted: 7 August 2018; Published: 9 August 2018 Abstract: In the present study, nontargeted metabolomics was used to screen the phenolic and polyhydroxy compounds in pepper products. A total of 186 phenolic and polyhydroxy compounds, including anthocyanins, proanthocyanidins, catechin derivatives, flavanones, flavones, flavonols, isoflavones and 3-O-p-coumaroyl quinic acid O-hexoside, quinic acid (polyhydroxy compounds), etc. For the selected 50 types of phenolic compound, except malvidin 3,5-diglucoside (malvin), 0 L-epicatechin and 4 -hydroxy-5,7-dimethoxyflavanone, other compound contents were present in high contents in freeze-dried pepper berries, and pinocembrin was relatively abundant in two kinds of pepper products. The score plots of principal component analysis indicated that the pepper samples can be classified into four groups on the basis of the type pepper processing.
    [Show full text]
  • Revisiting Greek Propolis: Chromatographic Analysis and Antioxidant Activity Study
    RESEARCH ARTICLE Revisiting Greek Propolis: Chromatographic Analysis and Antioxidant Activity Study Konstantinos M. Kasiotis1*, Pelagia Anastasiadou1, Antonis Papadopoulos2, Kyriaki Machera1* 1 Benaki Phytopathological Institute, Department of Pesticides Control and Phytopharmacy, Laboratory of Pesticides' Toxicology, Kifissia, Athens, Greece, 2 Benaki Phytopathological Institute, Department of Phytopathology, Laboratory of Non-Parasitic Diseases, Kifissia, Athens, Greece * [email protected] (KMK); [email protected] (KM) Abstract a1111111111 Propolis is a bee product that has been extensively used in alternative medicine and recently a1111111111 a1111111111 has gained interest on a global scale as an essential ingredient of healthy foods and cosmet- a1111111111 ics. Propolis is also considered to improve human health and to prevent diseases such as a1111111111 inflammation, heart disease, diabetes and even cancer. However, the claimed effects are anticipated to be correlated to its chemical composition. Since propolis is a natural product, its composition is consequently expected to be variable depending on the local flora align- ment. In this work, we present the development of a novel HPLC-PDA-ESI/MS targeted OPEN ACCESS method, used to identify and quantify 59 phenolic compounds in Greek propolis hydroalco- holic extracts. Amongst them, nine phenolic compounds are herein reported for the first time Citation: Kasiotis KM, Anastasiadou P, Papadopoulos A, Machera K (2017) Revisiting in Greek propolis. Alongside GC-MS complementary analysis was employed, unveiling Greek Propolis: Chromatographic Analysis and eight additional newly reported compounds. The antioxidant activity study of the propolis Antioxidant Activity Study. PLoS ONE 12(1): samples verified the potential of these extracts to effectively scavenge radicals, with the e0170077. doi:10.1371/journal.pone.0170077 extract of Imathia region exhibiting comparable antioxidant activity to that of quercetin.
    [Show full text]
  • Apigenin 520-36-5
    SUMMARY OF DATA FOR CHEMICAL SELECTION Apigenin 520-36-5 BASIS OF NOMINATION TO THE CSWG Apigenin is brought to the attention of the CSWG because of a recent scientific article citing this flavonoid as a substance that can be metabolically activated to produce toxic prooxidant phenoxyl radicals. Pure apigenin is used primarily in research as a protein kinase inhibitor that may suppress tumor promotion and that has anti-proliferating effects on human breast cancer cells and inhibitory actions on MAP kinase. Apigenin is also one of several active ingredients in the popular herbal remedy, chamomile. Apigenin is found naturally in many fruits and vegetables, including apples and celery. It is found in several popular spices, including basil, oregano, tarragon, cilantro, and parsley. As a representative of flavonoids containing phenol B rings that may induce lipid peroxidation, apigenin is a candidate for testing. SELECTION STATUS ACTION BY CSWG: 12/12/00 Studies requested: Developmental toxicity Short-term tests for chromosomal aberrations Priority: None assigned Rationale/Remarks: Nomination based on concerns about apigenin’s potential to produce possibly toxic radicals and its estrogenic activity NCI will conduct a mouse lymphoma assay Apigenin 520-36-5 CHEMICAL IDENTIFICATION CAS Registry Number: 520-36-5 Chemical Abstracts Service Name: 4H-1-benzopyran-4-one,5,7-dihydroxy-2-(4- hydroxy-phenyl)- (9CI) Synonyms and Trade Names: Apigenin; apigenine; apigenol; chamomile; C.I. natural yellow 1; 2-(p-hydroxyphenyl)-5,7- dihydroxy-chromone; spigenin; 4',5,7- trihydroxyflavone Structural Class: Flavone Structure, Molecular Formula and Molecular Weight: OH HO O OH O C15H10O5 Mol.
    [Show full text]
  • Phenolic Compounds and Uses in Fruit Growing A,B Melekber SULUSOGLU * Akocaeli University, Arslanbey Agricultural Vocational School, TR-41285, Kocaeli/Turkey
    Turkish Journal of Agricultural and Natural Sciences Special Issue: 1, 2014 TÜRK TURKISH TARIM ve DOĞA JOURNAL of AGRICULTURAL BİLİMLERİ DERGİSİ and NATURAL SCIENCES www.turkjans.com Phenolic Compounds and Uses in Fruit Growing a,b Melekber SULUSOGLU * aKocaeli University, Arslanbey Agricultural Vocational School, TR-41285, Kocaeli/Turkey. bKocaeli University, Graduate School of Natural and Applied Sciences, Department of Horticulture, TR-41380, Kocaeli/Turkey *Corresponding author: [email protected] Abstract Phenolic compounds are a class of chemical compounds in organic chemistry which consist of a hydroxyl group directly bonded to an aromatic hydrocarbon group. Phenolic compounds find in cell wall structures and play a major role in the growth regulation of plant as an internal physiological regulators or chemical messengers. They are used in the fruit growing field. They are related with defending system against pathogens and stress. They increase the success of tissue culture; can be helpful to identification of fruit cultivars, to determination of graft compatibility and identification of vigor of trees. They are also important because of their contribution to the sensory quality of fruits during the technological processes. In this review, the simple classification was given for these compounds and uses in the agricultural field were described. Key words: Phenolic compounds, fruit quality, fruit growing, cultivar identification, grafting, tree vigor Fenolik Bileşikler ve Meyve Yetiştiriciliğinde Kullanımı Özet Aromatik hidrokarbon grubuna bağlı bir hidroksil grubu içeren fenolik bileşikler organik kimyanın bir sınıfıdır. Fenolik bileşikler hücre duvarı yapısında bulunmakta ve içsel bir fizyolojik düzenleyici veya kimyasal haberci olarak bitki büyümesinin organizasyonunda önemli rol oynamaktadır. Meyve yetiştiriciliği alanında kullanılmaktadır.
    [Show full text]
  • 48003 Hughes Et Al 2017 Accepted Version.Pdf
    ResearchOnline@JCU This is the Accepted Version of a paper published in the Journal: Critical Reviews in Food Science and Nutrition Hughes, Samuel D., Ketheesan, Natkunam, and Haleagrahara, Nagaraja (2017) The therapeutic potential of plant flavonoids on rheumatoid arthritis. Critical Reviews in Food Science and Nutrition, 57 (17). pp. 3601-3613. http://dx.doi.org/10.1080/10408398.2016.1246413 © 2015. This manuscript version is made available under the CC-BY-NC-ND 4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0/ Critical Reviews in Food Science and Nutrition ISSN: 1040-8398 (Print) 1549-7852 (Online) Journal homepage: http://www.tandfonline.com/loi/bfsn20 The Therapeutic Potential of Plant Flavonoids on Rheumatoid Arthritis Samuel D. Hughes, Natkunam Ketheesan & Nagaraja Haleagrahara To cite this article: Samuel D. Hughes, Natkunam Ketheesan & Nagaraja Haleagrahara (2016): The Therapeutic Potential of Plant Flavonoids on Rheumatoid Arthritis, Critical Reviews in Food Science and Nutrition, DOI: 10.1080/10408398.2016.1246413 To link to this article: http://dx.doi.org/10.1080/10408398.2016.1246413 Accepted author version posted online: 22 Nov 2016. Submit your article to this journal Article views: 122 View related articles View Crossmark data Full Terms & Conditions of access and use can be found at http://www.tandfonline.com/action/journalInformation?journalCode=bfsn20 Download by: [JAMES COOK UNIVERSITY] Date: 23 March 2017, At: 16:37 ACCEPTED MANUSCRIPT The Therapeutic Potential of Plant Flavonoids on Rheumatoid Arthritis Samuel D. Hughes1, Natkunam Ketheesan2 & Nagaraja Haleagrahara3,* 1,2,3Biomedicine, College of Public Health, Medical & Veterinary Sciences, and 2, 3Australian Institute of Tropical Health and Medicine (AITHM), James Cook University, Townsville, Australia *Address correspondence to: Nagaraja Haleagrahara, Biomedicine, College of Public Health, Medical & Veterinary Sciences, James Cook University, Townsville, Australia.
    [Show full text]
  • EP1776161B1.Pdf
    (19) TZZ____T (11) EP 1 776 161 B1 (12) EUROPEAN PATENT SPECIFICATION (45) Date of publication and mention (51) Int Cl.: of the grant of the patent: A61Q 5/02 (2006.01) A61Q 7/00 (2006.01) 26.10.2016 Bulletin 2016/43 A61Q 19/00 (2006.01) A61K 8/36 (2006.01) A61K 8/362 (2006.01) A61K 8/37 (2006.01) (2006.01) (2006.01) (21) Application number: 05718804.7 A61K 8/39 A61Q 1/02 A61Q 5/06 (2006.01) A61K 8/64 (2006.01) A61Q 5/12 (2006.01) A61Q 11/00 (2006.01) (22) Date of filing: 25.04.2005 A61K 8/81 (2006.01) A61Q 19/06 (2006.01) A61Q 19/08 (2006.01) A61K 8/97 (2006.01) A61K 8/42 (2006.01) A61K 8/49 (2006.01) A61Q 5/00 (2006.01) A61K 8/73 (2006.01) (86) International application number: PCT/IB2005/051344 (87) International publication number: WO 2005/102266 (03.11.2005 Gazette 2005/44) (54) COSMETIC OR DERMOPHARMACEUTICAL COMPOSITION COMPRISING AT LEAST ONE UDP GLUCURONOSYL TRANSFERASE (UGT) ENZYMES INDUCER KOSMETISCHE ODER DERMOPHARMAZEUTISCHE ZUSAMMENSETZUNG MIT MINDESTENS EINEM UDP-GLUCURONOSYL-TRANSFERASE (UGT) ENZYM-INDUKTOR COMPOSITION COSMETIQUE OU DERMOPHARMACEUTIQUE COMPRENANT AU MOINS UN INDUCTEUR D’ENZYMES UDP-GLUCURONOSYLTRANSFERASES (UGT) (84) Designated Contracting States: • PATENT ABSTRACTS OF JAPAN vol. 2000, no. DE ES FR GB IT 14, 5 March 2001 (2001-03-05) & JP 2000 319154 A(NIPPON MENAADEKESHOHIN KK; ICHIMARU (30) Priority: 26.04.2004 FR 0404408 PHARCOS CO LTD), 21 November 2000 (2000-11-21) (43) Date of publication of application: • DATABASE WPI Derwent Publications Ltd., 25.04.2007 Bulletin 2007/17 London, GB; AN 2001-481491 XP002309671 CHEOUNG J H ET AL.: "Chrysin 7-o-crotonate, its (73) Proprietor: Sederma S.A.S.
    [Show full text]
  • Identification of Compounds That Rescue Otic And
    bioRxiv preprint doi: https://doi.org/10.1101/520056; this version posted January 16, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. 1 Identification of compounds that rescue otic and myelination defects in the 2 zebrafish adgrg6 (gpr126) mutant 3 4 Elvira Diamantopoulou1,*, Sarah Baxendale1,*, Antonio de la Vega de León2, Anzar Asad1, 5 Celia J. Holdsworth1, Leila Abbas1, Valerie J. Gillet2, Giselle R. Wiggin3 and Tanya T. 6 Whitfield1# 7 8 1Bateson Centre and Department of Biomedical Science, University of Sheffield, Sheffield, 9 S10 2TN, UK 10 2Information School, University of Sheffield, Sheffield, S1 4DP, UK 11 3Sosei Heptares, Steinmetz Building, Granta Park, Cambridge, CB21 6DG, UK 12 13 *These authors contributed equally 14 15 #Corresponding author: 16 Tanya T. Whitfield: [email protected] 17 ORCID iD: 0000-0003-1575-1504 18 19 Key words: zebrafish, aGPCR, Adgrg6, Gpr126, phenotypic screening, chemoinformatics, 20 versican, myelination, inner ear, lateral line, Schwann cells 21 22 1 bioRxiv preprint doi: https://doi.org/10.1101/520056; this version posted January 16, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. 23 ABSTRACT 24 Adgrg6 (Gpr126) is an adhesion class G protein-coupled receptor with a conserved role in 25 myelination of the peripheral nervous system.
    [Show full text]
  • Autophagy: a Potential Therapeutic Target of Polyphenols in Hepatocellular Carcinoma
    cancers Review Autophagy: A Potential Therapeutic Target of Polyphenols in Hepatocellular Carcinoma Chandramohan Kiruthiga 1, Kasi Pandima Devi 1,* , Seyed M. Nabavi 2 and Anupam Bishayee 3,* 1 Department of Biotechnology, Alagappa University (Science Campus), Karaikudi 630 003, Tamil Nadu, India; [email protected] 2 Applied Biotechnology Research Center, Baqiyatallah University of Medical Sciences, Tehran 1435916471, Iran; [email protected] 3 Lake Erie College of Osteopathic Medicine, Bradenton, FL 34211, USA * Correspondence: [email protected] (K.P.D.); [email protected] or [email protected] (A.B.); Tel.: +91-4565223325 (K.P.D.); +1-941-782-5950 (A.B.) Received: 15 January 2020; Accepted: 26 February 2020; Published: 29 February 2020 Abstract: Autophagy is a conserved biological phenomenon that maintains cellular homeostasis through the clearing of damaged cellular components under cellular stress and offers the cell building blocks for cellular survival. Aberrations in autophagy subsidize to various human pathologies, such as dementia, cardiovascular diseases, leishmaniosis, influenza, hepatic diseases, and cancer, including hepatocellular carcinoma (HCC). HCC is the fifth common mortal type of liver cancer globally, with an inhomogeneous topographical distribution and highest incidence tripled in men than women. Existing treatment procedures with liver cancer patients result in variable success rates and poor prognosis due to their drug resistance and toxicity. One of the pathophysiological mechanisms that are targeted during the development of anti-liver cancer drugs is autophagy. Generally, overactivated autophagy may lead to a non-apoptotic form of programmed cell death (PCD) or autophagic cell death or type II PCD. Emerging evidence suggests that manipulation of autophagy could induce type II PCD in cancer cells, acting as a potential tumor suppressor.
    [Show full text]
  • Quantitative Structure–Activity Relationships for the Flavonoid-Mediated Inhibition of P-Glycoprotein in KB/MDR1 Cells
    molecules Article Quantitative Structure–Activity Relationships for the Flavonoid-Mediated Inhibition of P-Glycoprotein in KB/MDR1 Cells Mengmeng Xia , Yajing Fang, Weiwei Cao, Fuqiang Liang , Siyi Pan and Xiaoyun Xu * Key Laboratory of Environment Correlative Dietology (Huazhong Agricultural University), Ministry of Education, Wuhan 430070, China; [email protected] (M.X.); [email protected] (Y.F.); [email protected] (W.C.); [email protected] (F.L.); [email protected] (S.P.) * Correspondence: [email protected] ; Tel.: +86-27-87671056; Fax: +86-27-87288373 Received: 16 April 2019; Accepted: 24 April 2019; Published: 27 April 2019 Abstract: P-glycoprotein (P-gp) serves as a therapeutic target for the development of inhibitors to overcome multidrug resistance (MDR) in cancer cells. In order to enhance the uptake of chemotherapy drugs, larger amounts of P-gp inhibitors are required. Besides several chemically synthesized P-gp inhibitors, flavonoids as P-gp inhibitors are being investigated, with their advantages including abundance in our daily diet and a low toxicity. The cytotoxicity of daunorubicin (as a substrate of P-gp) to KB/MDR1 cells and the parental KB cells was measured in the presence or absence of flavonoids. A two-dimensional quantitative structure–activity relationship (2D-QSAR) model was built with a high cross-validation coefficient (Q2) value of 0.829. Descriptors including vsurf_DW23, E_sol, Dipole and vsurf_G were determined to be related to the inhibitory activity of flavonoids. The lack of 2,3-double bond, 30-OH, 40-OH and the increased number of methoxylated substitutions were shown to be beneficial for the inhibition of P-gp.
    [Show full text]
  • Non-Nutrient, Naturally Occurring Phenolic Compounds with Antioxidant Activity for the Prevention and Treatment of Periodontal Diseases
    Antioxidants 2015, 4, 447-481; doi:10.3390/antiox4030447 OPEN ACCESS antioxidants ISSN 2076-3921 www.mdpi.com/journal/antioxidants Review Non-Nutrient, Naturally Occurring Phenolic Compounds with Antioxidant Activity for the Prevention and Treatment of Periodontal Diseases Alfonso Varela-López 1, Pedro Bullón 2, Francesca Giampieri 3 and José L. Quiles 1,* 1 Department of Physiology, Institute of Nutrition and Food Technology “José Mataix”, Biomedical Research Center (CIBM), University of Granada, Armilla, Avda. del Conocimiento s.n., 18100 Armilla, Spain; E-Mail: [email protected] 2 Department of Periodontology, Dental School, University of Sevilla, C/Avicena s.n., 41009 Sevilla, Spain; E-Mail: [email protected] 3 Department of Clinical Sciences, Marche Polytechnic University, Ancona 60100, Italy; E-Mail: [email protected] * Author to whom correspondence should be addressed; E-Mail: [email protected]; Tel.: +34-958-241-000 (ext. 20316). Academic Editor: Maurizio Battino Received: 9 March 2015 / Accepted: 29 May 2015 / Published: 24 June 2015 Abstract: One of the main factors able to explain the pathophysiological mechanism of inflammatory conditions that occur in periodontal disease is oxidative stress. Given the emerging understanding of this relationship, host-modulatory therapies using antioxidants could be interesting to prevent or slow the breakdown of soft and hard periodontal tissues. In this context, non-nutrient phenolic compounds of various foods and plants have received considerable attention in the last decade. Here, studies focusing on the relationship between different compounds of this type with periodontal disease have been collected. Among them, thymoquinone, coenzyme Q (CoQ), mangiferin, resveratrol, verbascoside and some flavonoids have shown to prevent or ameliorate periodontal tissues damage in animal models.
    [Show full text]